PharmacoEconomics & Outcomes News

July 2014, Volume 706, Issue 1, pp 16–16 | Cite as

Tecfidera to be reimbursed for MS patients in British Columbia

Media release

First Online: 05 July 2014

• 32 Downloads

This is a preview of subscription content, log in to check access.

Reference

1. Biogen Idec. British Columbia to Reimburse TECFIDERA(Tm), a First-Line Oral Treatment for Multiple Sclerosis. Media Release : 25 Jun 2014Google Scholar

Copyright information

© Springer International Publishing Switzerland 2014